Evidence map›Paper›PMID 29867038›Full record

ReviewPharmaceuticals (Basel, Switzerland)2018

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.

Dario Siniscalco, Stephen Schultz, Anna Lisa Brigida, Nicola Antonucci

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 146 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 5 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05218577 nacompletednot on this mapstarted 2021, after this paper: background citation

The Effect of High Selenium Functional Food and Selenium Supplement on Developmental Level in Autism Spectrum Disorder

TypeinterventionalSponsorNeny TrianaRan2021 to 2021Enrolled65ConditionsAutism Spectrum DisorderArmshigh selenium functional food, selenium supplement, Placebo
NCT05363982 nacompletednot on this mapstarted 2022, after this paper: background citation

Evaluation of Transcranial Photobiomodulation in Autism Spectrum Disorder: Double-Blind, Placebo-Controlled, Randomized Clinical Study of a Novel Approach

TypeinterventionalSponsorMassachusetts General HospitalRan2022 to 2024Enrolled41ConditionsAutism Spectrum DisorderArmsTranscranial Photobiomodulation (tPBM), Placebo/ Sham
3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 5 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Maternal Dietary Factors and the Risk of Autism Spectrum Disorders: A Systematic Review of Existing Evidence.Autism research : official journal of the International Society for Autism Research · 2020
    Pooled it
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. A Developmental Neuroimmune Cascade Model of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Emerging role ofFrontiers in molecular neuroscience · 2026
    Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dario SiniscalcoDepartment of Experimental Medicine, University of Campania, 80138 Naples, Italy. dariosin@uab.edu.
Stephen SchultzDepartment of Cellular and Integrative Physiology, School of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. stevendri0629@gmail.com.
Anna Lisa BrigidaItalian Group for Study Autism-GISA, 25018 Brescia, Italy. brigida.annalisa@gmail.com.
Nicola AntonucciBiomedical Centre for Autism Research and Treatment, 70124 Bari, Italy. info@antonucci.eu.
La Forza del Silenzio · ITThe University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication and interaction and restricted-repetitive patterns of behavior, interests, or activities. Strong inflammation states are associated with ASD. This inflammatory condition is often linked to immune system dysfunction. Several cell types are enrolled to trigger and sustain these processes. Neuro-inflammation and neuro-immune abnormalities have now been established in ASD as key factors in its development and maintenance. In this review, we will explore inflammatory conditions, dysfunctions in neuro-immune cross-talk, and immune system treatments in ASD management.

Indexed as

autisminflammationmacrophagesmonocytesneuro-immune system

Identifiers

PMID29867038
PMCPMC6027314
OpenAlexW2805645615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.